KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cardlytics (CDLX) Current Assets (2017 - 2025)

Cardlytics (CDLX) has disclosed Current Assets for 9 consecutive years, with $137.3 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Current Assets fell 22.87% year-over-year to $137.3 million, compared with a TTM value of $137.3 million through Dec 2025, down 22.87%, and an annual FY2025 reading of $137.3 million, down 22.87% over the prior year.
  • Current Assets was $137.3 million for Q4 2025 at Cardlytics, down from $140.7 million in the prior quarter.
  • Across five years, Current Assets topped out at $702.6 million in Q1 2021 and bottomed at $137.3 million in Q4 2025.
  • Average Current Assets over 5 years is $252.3 million, with a median of $221.1 million recorded in 2023.
  • The sharpest move saw Current Assets skyrocketed 313.18% in 2021, then crashed 54.53% in 2022.
  • Year by year, Current Assets stood at $358.7 million in 2021, then crashed by 30.3% to $250.0 million in 2022, then fell by 10.44% to $223.9 million in 2023, then decreased by 20.52% to $178.0 million in 2024, then fell by 22.87% to $137.3 million in 2025.
  • Business Quant data shows Current Assets for CDLX at $137.3 million in Q4 2025, $140.7 million in Q3 2025, and $150.4 million in Q2 2025.